Conclusion.

Back

Open Access

Conclusion.

Session: SGLT2 inhibition across the spectrum of heart failure: maximizing patient benefits in clinical practice

Topic: Chronic Heart Failure

Speaker: Professor C. Lam (Singapore, SG)

Organised by Charité Friends & Sponsors Trust

Event: Heart Failure 2022

Congress Presentation

About the speaker

Professor Carolyn S P Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)

166 presentations

56 followers

5 more presentations in this session

Welcome and introduction.

Speaker: Professor S. Anker (Berlin, DE)

Access

Slides

Video

Optimizing foundational therapies in HF ‒ can we do better?

Speaker: Professor A. Stewart Coats (Sydney, AU)

Access

Slides

Video

SGLT2 inhibition ‒ early, first-line therapy across the spectrum of HF.

Speaker: Doctor D. Tomasoni (Brescia, IT)

Access

Slides

Video

SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion.

Speaker: Professor G. Rosano (London, GB)

Access

Slides

Video

Interactive panel discussion.

Speaker: Professor S. Anker (Berlin, DE) Professor A. Stewart Coats (Sydney, AU) Doctor D. Tomasoni (Brescia, IT) Professor G. Rosano (London, GB)

Access

Video

Access the full session

SGLT2 inhibition across the spectrum of heart failure: maximizing patient benefits in clinical practice

Speakers: Professor C. Lam, Professor S. Anker, Professor A. Stewart Coats, Doctor D. Tomasoni, Professor G. Rosano...

Access

Video

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources